Mechanism of interleukin-13 production by granulocyte-macrophage colony-stimulating factor-dependent macrophages via protease-activated receptor-2

被引:22
|
作者
Yamaguchi, Rui [1 ,2 ]
Yamamoto, Takatoshi [1 ]
Sakamoto, Arisa [1 ]
Ishimaru, Yasuji [1 ]
Narahara, Shinji [1 ]
Sugiuchi, Hiroyuki [1 ]
Hirose, Eiji [1 ]
Yamaguchi, Yasuo [1 ]
机构
[1] Kumamoto Hlth Sci Univ, Grad Sch Med Sci, Kumamoto 8615598, Japan
[2] Kumamoto Univ, Sch Med, Grad Sch Med Sci, Kumamoto 860, Japan
关键词
Extracellular signal-regulated kinase; Granulocyte-macrophage colony-stimulating factor; Interleukin-13; Neutrophil elastase; Protease-activated receptor-2; SIGNAL-REGULATED KINASE; CYTOKINE PRODUCTION; MAP KINASE; P38; INHIBITION; PATHWAY; ERK; PHOSPHORYLATION; LYMPHOCYTES; EXPRESSION;
D O I
10.1016/j.bcmd.2015.03.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Granulocyte-macrophage colony-stimulating factor (GM-CSF) promotes classically activated M1 macrophages. GM-CSF upregulates protease-activated receptor-2 (PAR-2) protein expression and activation of PAR-2 by human neutrophil elastase (HNE) regulates cytokine production. Aim: This study investigated the mechanism of PAR-2-mediated interleukin (IL)-13 production by GM-CSF-dependent macrophages stimulated with HNE. Methods: Adherent macrophages were obtained from primary cultures of human mononuclear cells. After stimulation with HNE to activate the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERIC) signaling pathway, IL-13 mRNA and protein levels were assessed by the reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. Results: PAR-2 protein was detected in GM-CSF-dependent macrophages by Western blotting. Unexpectedly, PD98059 (an ERK1 inhibitor) increased IL-13 production, even at higher concentrations. Interestingly, U0126 (an ERK1/2 inhibitor) reduced IL-13 production in a concentration-dependent manner. Neither SB203580 (a p38alpha/p38beta inhibitor) nor BIRB796 (a p38gamma/p38delta inhibitor) affected IL-13 production, while TMB-8 (a calcium chelator) diminished IL-13 production. Discussion: Stimulation with HNE promoted the production of IL-13 (a Th2 cytokine) by GM-CSF-dependent M1 macrophages. PAR-2-mediated IL-13 production may be dependent on the Ca2+/ERK2 signaling pathway. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
  • [1] Granulocyte-macrophage colony-stimulating factor primes interleukin-13 production by macrophages via protease-activated receptor-2
    Aoki, Manabu
    Yamaguchi, Rui
    Yamamoto, Takatoshi
    Ishimaru, Yasuji
    Ono, Tomomichi
    Sakamoto, Arisa
    Narahara, Shinji
    Sugiuchi, Hiroyuki
    Hirose, Eiji
    Yamaguchi, Yasuo
    BLOOD CELLS MOLECULES AND DISEASES, 2015, 54 (04) : 353 - 359
  • [2] Expression of chimeric granulocyte-macrophage colony-stimulating factor/interleukin 2 receptors in human cytotoxic T lymphocyte clones results in granulocyte-macrophage colony-stimulating factor-dependent growth
    Evans, LS
    Witte, PR
    Feldhaus, AL
    Nelson, BH
    Riddell, SR
    Greenberg, PD
    Lupton, SD
    Jones, LA
    HUMAN GENE THERAPY, 1999, 10 (12) : 1941 - 1951
  • [3] BOMBESIN INCREASES THE PRODUCTION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR BY ALVEOLAR MACROPHAGES
    AGUAYO, SM
    JANSON, RW
    KING, TE
    CLINICAL RESEARCH, 1991, 39 (04): : A846 - A846
  • [4] INTERLEUKIN-1 SYNERGIZES WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ON GRANULOCYTIC COLONY FORMATION BY INTERMEDIATE PRODUCTION OF GRANULOCYTE COLONY-STIMULATING FACTOR
    SCHAAFSMA, MR
    FALKENBURG, JHF
    DUINKERKEN, N
    VANDAMME, J
    ALTROCK, BW
    WILLEMZE, R
    FIBBE, WE
    BLOOD, 1989, 74 (07) : 2398 - 2404
  • [5] The molecular mechanism of action of granulocyte-macrophage colony-stimulating factor
    Kwon, EM
    Sakamoto, KM
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (08) : 442 - 446
  • [6] GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR MIMICRY AND RECEPTOR INTERACTIONS
    VONFELDT, JM
    MONFARDINI, C
    KIEBEREMMONS, T
    VOET, D
    WEINER, DB
    WILLIAMS, WV
    IMMUNOLOGIC RESEARCH, 1994, 13 (2-3) : 96 - 109
  • [7] CHARACTERIZATION OF THE HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR
    DIPERSIO, J
    BILLING, P
    KAUFMAN, S
    EGHTESADY, P
    WILLIAMS, RE
    GASSON, JC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (04) : 1834 - 1841
  • [8] Immunomodulation of peritoneal macrophages by granulocyte-macrophage colony-stimulating factor in humans
    Selgas, R
    DeCastro, MF
    Jimenez, C
    Carcamo, C
    Contreras, T
    Bajo, MA
    Vara, F
    Corbi, A
    KIDNEY INTERNATIONAL, 1996, 50 (06) : 2070 - 2078
  • [9] Production of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor by carcinomas in a dog and a cat with paraneoplastic leukocytosis
    Sharkey, LC
    Rosol, IJ
    Grone, A
    Ward, H
    Steinmeyer, C
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 1996, 10 (06) : 405 - 408
  • [10] DIFFERENTIAL MODULATION OF MACROPHAGE PROLIFERATION IN RESPONSE TO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND MACROPHAGE COLONY-STIMULATING FACTOR BY INTERLEUKIN-4
    CHEN, BDM
    FAN, K
    RUAN, QY
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 509 - 509